nicholas piramal india ltd deal signed with merck to develop cancer drugs nicholas piramal india ltd said it signed a pact with merck &amp co to conduct research and develop new oncology drugs the indian company will be responsible for taking two selected targets provided by merck from the discovery stage to midstage clinical trials merck of whitehouse station n j will advance the most promising drugs into late stage clinical trials and then commercialize them nicholas said it will be eligible for milestone payments of up to &# million per target from merck as the drugs are developed it will receive royalties on the sale of any products resulting from the collaboration "this agreement furthers our strategy of building global alliances that expand and advance mercks pipeline especially in countries such as india with rapidly expanding drug discovery competencies " merck said 
